R97.21

Billable
ChapterR00–R99
Ranksubcategory
Official Description

Rising PSA following treatment for malignant neoplasm of prostate

Metadata & Insights
  • Billable/specific code (valid for reimbursement).
  • Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (R00-R99).
General instructions are available for the parent sections:

Clinical Hierarchy

BillableHas subcodes
CH18Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
R97Abnormal tumor markers
R97.2Elevated prostate specific antigen [PSA]
R97.21Rising PSA following treatment for malignant neoplasm of prostateBillable

Applicable Ancestor Context

The following parent sections contain instructions or notes that apply to R97.21:

categoryR97
Abnormal tumor markers
View context instructions
chapterCH18
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
View context instructions

Code History

  • FY 2016: This code replaced R97.2 (Elevated prostate specific antigen [PSA])

MS-DRG Classification

2026 v43.1

This code is grouped within the following Diagnosis Related Group(s) for clinical reimbursement:

Cross Reference

Find Procedures (ICD-10-PCS)

Find surgical and procedural codes related to Rising PSA following treatment for malignant neoplasm of prostate.

Search PCS Codes